Trends in the hospital-sector consumption of the WHO AWaRe Reserve group antibiotics in EU/EEA countries and the United Kingdom, 2010 to 2018

  15 October 2022

Antimicrobial resistance (AMR) is a major global public health concern. The main driver of AMR development is the consumption of antimicrobial agents. Overall, in the European Union/European Economic Area and the United Kingdom (EU/EEA/UK), it is estimated that nearly one third of patients admitted to acute care hospitals are receiving at least one antimicrobial agent. The European Centre for Disease Prevention and Control (ECDC) estimated that, each year, there are ca 4.5 million healthcare-associated infections (HAIs) in acute care hospitals in the EU/EEA/UK. Approximately one-third of HAIs for which a microbiological result was obtained, was associated with antimicrobial-resistant bacteria.

Further reading: Eurosurveillance
Author(s): Ria Benkő et al
Effective Surveillance  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!